v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock Shares
Common Stock and Paid-In Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Stock Held in Trust
Beginning balance (in shares) at Dec. 31, 2024   92,926,000        
Beginning balance at Dec. 31, 2024 $ 1,324,805   $ 2,275,952 $ 963 $ (952,110) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   678,000        
Exercise of stock options 8,981   8,981      
Stock issued under ESPP (in shares)   115,000        
Stock issued under ESPP 2,880   2,880      
Issuance of common stock upon vesting of RSUs (in shares)   407,000        
Stock-based compensation 46,602   46,602      
Stock held in trust under deferred compensation plan 0   112     (112)
Other 11   11      
Other comprehensive income (loss) 658     658    
Net loss (212,411)       (212,411)  
Ending balance (in shares) at Jun. 30, 2025   94,126,000        
Ending balance at Jun. 30, 2025 1,171,526   2,334,538 1,621 (1,164,521) (112)
Beginning balance (in shares) at Mar. 31, 2025   93,525,000        
Beginning balance at Mar. 31, 2025 1,254,000   2,300,882 2,002 (1,048,884) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   463,000        
Exercise of stock options 4,529   4,529      
Stock issued under ESPP (in shares)   115,000        
Stock issued under ESPP 2,880   2,880      
Issuance of common stock upon vesting of RSUs (in shares)   23,000        
Stock-based compensation 26,124   26,124      
Stock held in trust under deferred compensation plan 0   112     (112)
Other 11   11      
Other comprehensive income (loss) (381)     (381)    
Net loss (115,637)       (115,637)  
Ending balance (in shares) at Jun. 30, 2025   94,126,000        
Ending balance at Jun. 30, 2025 1,171,526   2,334,538 1,621 (1,164,521) (112)
Beginning balance (in shares) at Dec. 31, 2025   95,575,000        
Beginning balance at Dec. 31, 2025 $ 992,083   2,407,757 1,865 (1,417,427) (112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 629,013 629,000        
Exercise of stock options $ 14,639   14,639      
Stock issued under ESPP (in shares)   159,000        
Stock issued under ESPP 4,281   4,281      
Issuance of common stock, net of transaction costs (in shares)   8,763,000        
Issuance of common stock, net of transaction costs 379,771   379,771      
Issuance of common stock upon vesting of RSUs (in shares)   682,000        
Stock-based compensation 54,761   54,761      
Stock held in trust under deferred compensation plan 0   1,151     (1,151)
Other comprehensive income (loss) (4,873)     (4,873)    
Net loss (248,700)       (248,700)  
Ending balance (in shares) at Jun. 30, 2026   105,808,000        
Ending balance at Jun. 30, 2026 1,191,962   2,862,360 (3,008) (1,666,127) (1,263)
Beginning balance (in shares) at Mar. 31, 2026   105,314,000        
Beginning balance at Mar. 31, 2026 1,280,646   2,828,204 (1,254) (1,545,272) (1,032)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   233,000        
Exercise of stock options 4,697   4,697      
Stock issued under ESPP (in shares)   159,000        
Stock issued under ESPP 4,281   4,281      
Issuance of common stock upon vesting of RSUs (in shares)   102,000        
Stock-based compensation 24,947   24,947      
Stock held in trust under deferred compensation plan 0   231     (231)
Other comprehensive income (loss) (1,754)     (1,754)    
Net loss (120,855)       (120,855)  
Ending balance (in shares) at Jun. 30, 2026   105,808,000        
Ending balance at Jun. 30, 2026 $ 1,191,962   $ 2,862,360 $ (3,008) $ (1,666,127) $ (1,263)